Atmospheric-pressure plasma technology deposits durable nanometre-thin polymer coatings that tune surface wetting from hydrophilic to hydrophobic without solvents or vacuum chambers. Suitable for polymer films, nonwovens, metals, and glass, it enables patterned wetting, fluid control, and low-friction surfaces in roll-to-roll manufacturing. Currently offered for sponsored research collaboration.
This technology uses atmospheric-pressure plasma to deposit nanometre-thin, covalently anchored polymer coatings that control surface wetting on demand. By selecting precursor chemistry and adjusting plasma energy, the coating can tune water contact angles from hydrophilic (<10°) to hydrophobic (>150° with surface texture) on polymer films, nonwovens, metals, and glass. The process is dry, solvent-free, near room temperature, and compatible with roll-to-roll manufacturing, making it suitable for consumer goods, medical materials, packaging, and fluid-handling applications.
The core value is durable wetting control without altering bulk properties. Because only the outermost nanometres of the surface are modified, mechanical strength, feel, and optics remain unchanged. Crosslinked plasma-polymer films resist hydrophobic recovery—a common failure of conventional plasma activation—and maintain stable surface energy against ageing, washing, and abrasion.
How it works:
Capabilities:
Applications: surface-energy mapping, patterned wetting for fluid control, low-friction or tuned-transfer coatings, durable hydrophobic/hydrophilic finishes, and hybrid topography–chemistry surfaces.
The technology is at the proof-of-concept stage. The proposing laboratory has an established plasma-coating track record and proposes a 12-month, three-phase sponsored research program: baseline and chemistry screening, pattern and friction tuning, and durability and scale-up validation. The first phase would produce a surface-energy map and coated coupons; later phases would include storage ageing, rub/wash cycling, and process-window definition. No commercial deployment is claimed.
Flinders University is a comprehensive public research university based in Adelaide with a growing footprint across South Australia. Its Tonsley campus sits inside the Tonsley Innovation District, placing researchers alongside industry, government, and startups in facilities designed for co-development and demonstration. The health and medical precinct integrates the university with Flinders Medical Centre and a new Health & Medical Research Building, enabling rapid clinical collaboration and translation. Research is supported by competitive funding from the Australian Research Council, the National Health and Medical Research Council, and the Medical Research Future Fund. A dedicated research partnerships and commercialisation team and an active entrepreneurship institute help industry engage, manage IP, and launch new ventures.